SEC Tracker
Get the app

TradeUP Acquisition ESLA

TradeUP Acquisition FY 2022: net loss $996K

Form
10-K
Filed
Period
Importance
Notable
Document
10-K

Key figures from this report

These are the numbers TradeUP Acquisition reported for the year ended Dec 31, 2022, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

  1. Net income−$996KAgainst −$248K in FY 202110-K income statement, on EDGAR
  2. Cash and cash equivalents$41K−91% from $479K in FY 202110-K balance sheet, on EDGAR
  3. Cash from operations−$1.0MAgainst −$316K in FY 202110-K cash flow statement, on EDGAR

Every year in the financial tables

View on EDGAR

Open in the app

Get an email when TradeUP Acquisition files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Fibrogen FGEN public float $21M, Jun 30, 2025
  2. Armata Pharmaceuticals ARMP public float $21M, Jun 30, 2025
  3. Imunon IMNN public float $21M, Jun 30, 2025
  4. Lunai Bioworks LNAI public float $21M, Dec 31, 2025
  5. Dare Bioscience DARE public float $21M, Jun 30, 2025